Her doctor fought to keep her on the GLP-1 agonist, the category that includes weight loss and Type 2 diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound
CHALLENGES TO DEVELOPMENT In developing the second-generation amylin-analog cagrilintide there were 2 main barriers: (1) to prevent amylin protein aggregation and (2) to extend the amylin-analogs half-life
Hipersensibilidad : extremadamente rara
no means no routine funding (so patient groups may have to rely on special funds or waivers, which are limited)
For example, following a heart-healthy diet like the Mediterranean diet, which is rich in fruits, vegetables, whole grains, lean proteins, and healthy fats, can improve both blood sugar management and cardiovascular health